NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

India's Benchmark Index Expected to Trade in 28,000-30,000 Range by End of FY27

Despite the Nifty 50 declining more than 9% this year, smallcase managers remain optimistic about the outlook for FY27, expecting India's benchmark index to trade in the 28,000–30,000 range by the end of the financial year. This potential upside of nearly 15%–25% from current levels is supported by continued strength in sectors such as Banking, Capital Goods, Telecom, and domestic manufacturing themes.

The next phase of the market rally is likely to be driven by earnings growth rather than valuation expansion, with investors expected to focus more on sustainable profitability, execution strength, and balance sheet quality instead of aggressive re-rating. Smallcase managers have projected earnings per share (EPS) estimates for the Nifty and Sensex in the range of ₹1,280–₹1,320. Based on the expected earnings trajectory, they expect the benchmark index to trade within a valuation band of 22x–24x, reflecting confidence in India's domestic growth momentum and corporate profitability.

Key Sectors to Watch

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Smallcase managers continue to remain constructive on sectors linked to India's domestic capex and manufacturing story. According to the report, large-cap stocks remained relatively resilient during the year, while broader markets witnessed sharp divergence, making stock selection increasingly important for investors. The managers also said FY26 rewarded companies with strong earnings visibility, pricing power, and healthy balance sheets rather than broad-based market growth.

SectorFY26 PerformanceExpected FY27 Performance
Capital Goods15%20%
Industrials18%25%
Defence12%18%
BFSI10%15%

Sectors such as capital goods, industrials, defence, and BFSI continue to offer strong earnings visibility and policy support. Defensive segments such as Pharma and select FMCG are expected to provide portfolio stability amid market volatility, while IT Services may offer gradual recovery opportunities as global demand conditions improve.

Risks Ahead

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

While managers remain bullish on the long-term India story, they also warned that the ongoing West Asia conflict could place pressure on India's macroeconomic indicators during FY27. Rising crude oil prices may increase India's oil import bill from around $123 billion in FY26 to nearly $132 billion in FY27, potentially widening India's current account deficit to nearly 1% of GDP compared with 0.7–0.8% in FY26.

The managers also cautioned that a sustained rise in crude oil prices could fuel inflationary pressures. Every 10% increase in crude oil prices could potentially raise WPI inflation by 80–100 basis points and CPI inflation by 40–60 basis points, thereby impacting economic growth.

Valuation Concerns

Certain pockets of the market are currently trading at historically elevated levels. The metals and mining space appears fully valued and vulnerable to correction, while financials and FMCG offer relatively better risk-reward opportunities. Private banks, NBFCs, and insurance companies are trading near cyclical valuation lows, whereas FMCG valuations have moderated closer to historical trough levels.

Investor Takeaway

Investors should focus on sustainable profitability, execution strength, and balance sheet quality for long-term growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.